首页 > 最新文献

British Journal of Surgery最新文献

英文 中文
Nationwide outcomes of 1000 robotic pancreatoduodenectomies across the four phases of the learning curve. 全国范围内1000例机器人胰十二指肠切除术在学习曲线的四个阶段的结果。
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-11-06 DOI: 10.1093/bjs/znaf210
Anouk M L H Emmen,Bram L J van den Broek,Tessa E Hendriks,Olivier R Busch,Bert A Bonsing,Marie L Cappelle,Peter-Paul L O Coene,Sebastiaan Festen,Erwin van der Harst,Ignace H J T de Hingh,Cees J H M van Laarhoven,Daan J Lips,Joost Sprakel,Misha D P Luyer,J Sven D Mieog,Hjalmar C van Santvoort,George van der Schelling,Jan H Wijsman,Gijs A Patijn,Roeland F de Wilde,Maurice J W Zwart,Wouter J M Derksen,I Quintus Molenaar,Bas Groot Koerkamp,Marc G Besselink,
BACKGROUNDRobotic pancreatoduodenectomy (RPD) is increasingly being implemented to enhance patient recovery, but it is unclear what happens to patient outcomes after the initial learning curve. The aim of this study was to evaluate the first 1000 consecutive RPD performed in the Netherlands.METHODSA nationwide analysis of patients who underwent RPD in 13 centres (March 2016-August 2023) from the Dutch Pancreatic Cancer Audit was performed. Patients were grouped based on published learning curve cut-offs (phases 1-4): 1-15, 16-62, 63-84, and >84 RPD per centre respectively. Outcomes were compared between the four learning curve phases. Ideal Outcome rates were used to compare outcomes between centres.RESULTSOverall, 1000 patients after RPD were included. The conversion rate was 10.1%, the rate of Clavien-Dindo complications of grade ≥III was 41.3%, the rate of postoperative pancreatic fistula of grade B/C was 24.4%, and the rate of in-hospital/30-day mortality was 3.9%. Of the patients, 71.1% had a high updated alternative fistula risk score. Improvements between the phases were found for five outcomes: median operating time (420, 360, 349, and 369 min respectively; P < 0.001), conversion rate (21.7%, 10.0%, 2.8%, and 7.5% respectively; P < 0.001), rate of delayed gastric emptying (DGE) of grade B/C (32.3%, 22.6%, 15.4%, and 20.2% respectively; P = 0.003), reoperation rate (9.9%, 11.3%, 9.8%, and 4.9% respectively; P = 0.026), and median duration of hospital stay (12, 11, 10, and 10 days respectively; P = 0.035). The rate of Clavien-Dindo complications of grade ≥III and the rate of in-hospital/30-day mortality remained stable. The Ideal Outcome rate (mean 47%) did not differ between centres.CONCLUSIONAcross four learning curve phases in a nationwide cohort, improvements were observed for operating time, conversion rate, rate of DGE of grade B/C, reoperation rate, and duration of hospital stay.
背景:机器人胰十二指肠切除术(RPD)越来越多地被用于提高患者的康复,但尚不清楚在最初的学习曲线之后患者的预后会发生什么。本研究的目的是评估在荷兰进行的前1000例连续RPD。方法对荷兰胰腺癌审计中13个中心(2016年3月- 2023年8月)接受RPD的患者进行全国性分析。根据公布的学习曲线截止值(1-4期)对患者进行分组:每个中心分别为1-15、16-62、63-84和bbb84 RPD。比较四个学习曲线阶段的结果。理想转归率用于比较中心间的转归。结果共纳入1000例RPD患者。转换率为10.1%,≥III级Clavien-Dindo并发症发生率为41.3%,术后B/C级胰瘘发生率为24.4%,住院/30天死亡率为3.9%。在患者中,71.1%具有较高的更新替代瘘风险评分。五项指标在各阶段间均有改善:手术时间中位数(分别为420、360、349和369 min, P < 0.001)、转换率(分别为21.7%、10.0%、2.8%和7.5%,P < 0.001)、B/C级胃排空延迟率(分别为32.3%、22.6%、15.4%和20.2%,P = 0.003)、再手术率(分别为9.9%、11.3%、9.8%和4.9%,P = 0.026)和住院时间中位数(分别为12、11、10和10天,P = 0.035)。≥III级Clavien-Dindo并发症发生率和住院/30天死亡率保持稳定。理想转归率(平均47%)在中心间无差异。结论在全国队列的四个学习曲线阶段中,观察到手术时间、转换率、B/C级DGE率、再手术率和住院时间的改善。
{"title":"Nationwide outcomes of 1000 robotic pancreatoduodenectomies across the four phases of the learning curve.","authors":"Anouk M L H Emmen,Bram L J van den Broek,Tessa E Hendriks,Olivier R Busch,Bert A Bonsing,Marie L Cappelle,Peter-Paul L O Coene,Sebastiaan Festen,Erwin van der Harst,Ignace H J T de Hingh,Cees J H M van Laarhoven,Daan J Lips,Joost Sprakel,Misha D P Luyer,J Sven D Mieog,Hjalmar C van Santvoort,George van der Schelling,Jan H Wijsman,Gijs A Patijn,Roeland F de Wilde,Maurice J W Zwart,Wouter J M Derksen,I Quintus Molenaar,Bas Groot Koerkamp,Marc G Besselink, ","doi":"10.1093/bjs/znaf210","DOIUrl":"https://doi.org/10.1093/bjs/znaf210","url":null,"abstract":"BACKGROUNDRobotic pancreatoduodenectomy (RPD) is increasingly being implemented to enhance patient recovery, but it is unclear what happens to patient outcomes after the initial learning curve. The aim of this study was to evaluate the first 1000 consecutive RPD performed in the Netherlands.METHODSA nationwide analysis of patients who underwent RPD in 13 centres (March 2016-August 2023) from the Dutch Pancreatic Cancer Audit was performed. Patients were grouped based on published learning curve cut-offs (phases 1-4): 1-15, 16-62, 63-84, and >84 RPD per centre respectively. Outcomes were compared between the four learning curve phases. Ideal Outcome rates were used to compare outcomes between centres.RESULTSOverall, 1000 patients after RPD were included. The conversion rate was 10.1%, the rate of Clavien-Dindo complications of grade ≥III was 41.3%, the rate of postoperative pancreatic fistula of grade B/C was 24.4%, and the rate of in-hospital/30-day mortality was 3.9%. Of the patients, 71.1% had a high updated alternative fistula risk score. Improvements between the phases were found for five outcomes: median operating time (420, 360, 349, and 369 min respectively; P < 0.001), conversion rate (21.7%, 10.0%, 2.8%, and 7.5% respectively; P < 0.001), rate of delayed gastric emptying (DGE) of grade B/C (32.3%, 22.6%, 15.4%, and 20.2% respectively; P = 0.003), reoperation rate (9.9%, 11.3%, 9.8%, and 4.9% respectively; P = 0.026), and median duration of hospital stay (12, 11, 10, and 10 days respectively; P = 0.035). The rate of Clavien-Dindo complications of grade ≥III and the rate of in-hospital/30-day mortality remained stable. The Ideal Outcome rate (mean 47%) did not differ between centres.CONCLUSIONAcross four learning curve phases in a nationwide cohort, improvements were observed for operating time, conversion rate, rate of DGE of grade B/C, reoperation rate, and duration of hospital stay.","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"18 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endovascular aortic arch repair with a triple branch arch device. 血管内主动脉弓修复与三支弓装置。
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-11-06 DOI: 10.1093/bjs/znaf227
Emanuele C Grasso,Roberto G Aru,Federico F Pennetta,Thomas Le Houérou,Dominique Fabre,Stéphan Haulon
INTRODUCTIONRepair of aortic arch aneurysms is challenging whether by open surgery or endovascular techniques. The aim of this study was to analyse the midterm outcomes of an innovative endovascular thoracic aortic stent-graft with a triple branch design (Cook Medical, Bloomington, IN, USA) and to compare the outcomes in patients with a retrograde or an antegrade branch for the left common carotid artery (LCCA).METHODSAll patients treated with the custom-made triple-branch arch device between October 2018 and April 2025 at a single tertiary-care hospital were enrolled. Demographics, co-morbidities, indication for the procedure, procedural details, and outcomes were recorded. The primary aim was to evaluate midterm clinical outcomes, including branch primary patency and reintervention rates. The secondary aim was to compare outcomes based on LCCA branch orientation.RESULTSSome patients were treated. Indications were degenerative (49%) or post-dissection (51%) arch aneurysms. Percutaneous approach was more common in the retrograde group (74% versus 24%, P < 0.001), which also had shorter operative times (160.5 versus 234.0 min, P < 0.001). Thirty-day stroke occurred in five patients (7%; 3% retrograde versus 11% antegrade, P = 0.361). Thirty-day mortality was 3% (3% versus 3%, P = 1) and postoperative heart failure developed in three patients (6% versus 3%, P = 0.599). Median follow-up was 35.8 months (i.q.r. 17.5-62.6 months). During follow-up, 8 patients died (11%) and 14 (19%) required reintervention. Branch primary patency was 100%.CONCLUSIONSEndovascular aortic arch repair with a triple-branch device is associated with favourable early outcomes. A retrograde LCCA branch orientation was associated with shorter operative times, and an increased potential for a totally percutaneous approach. Multicentre studies are required to confirm these findings and evaluate long-term outcomes.
主动脉弓动脉瘤的修复无论是采用开放手术还是血管内技术都具有挑战性。本研究的目的是分析具有三支设计的创新型血管内胸主动脉支架移植物(Cook Medical, Bloomington, IN, USA)的中期结果,并比较左颈总动脉(LCCA)逆行或顺行分支患者的结果。方法纳入2018年10月至2025年4月在一家三级医院接受定制三支弓装置治疗的所有患者。记录了人口统计学、合并症、手术适应症、手术细节和结果。主要目的是评估中期临床结果,包括分支初级通畅和再干预率。第二个目的是比较基于LCCA分支定位的结果。结果部分患者得到治疗。适应症为退行性动脉瘤(49%)或夹层后弓动脉瘤(51%)。经皮入路在逆行组更为常见(74%比24%,P < 0.001),手术时间也更短(160.5比234.0 min, P < 0.001)。5例患者发生30天卒中(7%;3%逆行vs 11%顺行,P = 0.361)。30天死亡率为3%(3%对3%,P = 1), 3例患者发生术后心力衰竭(6%对3%,P = 0.599)。中位随访时间为35.8个月(i.q.为17.5-62.6个月)。随访期间,8例患者死亡(11%),14例(19%)需要再干预。支初级通畅100%。结论采用三支装置修复血管主动脉弓具有良好的早期预后。逆行LCCA分支定向与较短的手术时间相关,并且增加了完全经皮入路的可能性。需要多中心研究来证实这些发现并评估长期结果。
{"title":"Endovascular aortic arch repair with a triple branch arch device.","authors":"Emanuele C Grasso,Roberto G Aru,Federico F Pennetta,Thomas Le Houérou,Dominique Fabre,Stéphan Haulon","doi":"10.1093/bjs/znaf227","DOIUrl":"https://doi.org/10.1093/bjs/znaf227","url":null,"abstract":"INTRODUCTIONRepair of aortic arch aneurysms is challenging whether by open surgery or endovascular techniques. The aim of this study was to analyse the midterm outcomes of an innovative endovascular thoracic aortic stent-graft with a triple branch design (Cook Medical, Bloomington, IN, USA) and to compare the outcomes in patients with a retrograde or an antegrade branch for the left common carotid artery (LCCA).METHODSAll patients treated with the custom-made triple-branch arch device between October 2018 and April 2025 at a single tertiary-care hospital were enrolled. Demographics, co-morbidities, indication for the procedure, procedural details, and outcomes were recorded. The primary aim was to evaluate midterm clinical outcomes, including branch primary patency and reintervention rates. The secondary aim was to compare outcomes based on LCCA branch orientation.RESULTSSome patients were treated. Indications were degenerative (49%) or post-dissection (51%) arch aneurysms. Percutaneous approach was more common in the retrograde group (74% versus 24%, P < 0.001), which also had shorter operative times (160.5 versus 234.0 min, P < 0.001). Thirty-day stroke occurred in five patients (7%; 3% retrograde versus 11% antegrade, P = 0.361). Thirty-day mortality was 3% (3% versus 3%, P = 1) and postoperative heart failure developed in three patients (6% versus 3%, P = 0.599). Median follow-up was 35.8 months (i.q.r. 17.5-62.6 months). During follow-up, 8 patients died (11%) and 14 (19%) required reintervention. Branch primary patency was 100%.CONCLUSIONSEndovascular aortic arch repair with a triple-branch device is associated with favourable early outcomes. A retrograde LCCA branch orientation was associated with shorter operative times, and an increased potential for a totally percutaneous approach. Multicentre studies are required to confirm these findings and evaluate long-term outcomes.","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"39 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient characteristics and perioperative outcomes in the Bypass Equipoise Sleeve Trial (BEST) compared to general metabolic bariatric practice in Sweden. 旁路平衡套筒试验(BEST)的患者特征和围手术期结果与瑞典一般代谢减肥实践的比较。
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-10-03 DOI: 10.1093/bjs/znaf187
Suzanne Hedberg,Erik Stenberg,Johanna Österberg,Ellen Andersson,Markku Peltonen,Erik Näslund,Martin Neovius,Anders Thorell,Torsten Olbers,Johan Ottosson,
{"title":"Patient characteristics and perioperative outcomes in the Bypass Equipoise Sleeve Trial (BEST) compared to general metabolic bariatric practice in Sweden.","authors":"Suzanne Hedberg,Erik Stenberg,Johanna Österberg,Ellen Andersson,Markku Peltonen,Erik Näslund,Martin Neovius,Anders Thorell,Torsten Olbers,Johan Ottosson, ","doi":"10.1093/bjs/znaf187","DOIUrl":"https://doi.org/10.1093/bjs/znaf187","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"26 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145261457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol use disorder and alcohol-related mortality after metabolic bariatric surgery: prospective controlled cohort study. 代谢减肥手术后酒精使用障碍和酒精相关死亡率:前瞻性对照队列研究
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-10-03 DOI: 10.1093/bjs/znaf211
Kajsa Sjöholm,Markku Peltonen,Peter Jacobson,Johanna C Andersson-Assarsson,Sofie Ahlin,Lucas Adméus,Ida Arnetorp,My Engström,Magdalena Taube,Lena M S Carlsson,Per-Arne Svensson
BACKGROUNDA body of evidence supports a link between metabolic bariatric surgery (MBS) and alcohol use disorder (AUD), while the possible contribution to alcohol-related mortality remains unclear. The aim of this study was to examine the association between MBS and the risk of AUD and alcohol-related mortality over up to 35 years.METHODSThe Swedish Obese Subjects (SOS) study enrolled 2007 participants with severe obesity who underwent MBS and 2040 matched controls (median follow-up 25.2 years). Patients in the surgery group underwent gastric bypass (GBP; 266 patients), gastric banding (376 patients), or vertical banded gastroplasty (VBG; 1365 patients). The matched controls received the customary treatment for severe obesity at their primary healthcare centres. Data on AUD diagnoses and alcohol-related mortality were captured from the Swedish National Patient Register and the Swedish Cause of Death Register respectively.RESULTSDuring long-term follow-up, a significant difference in the incidence of AUD was found across surgery groups (log rank P < 0.001). Patients who underwent GBP exhibited the highest AUD risk (adjusted HR (HRadj) 5.07 (95% c.i. 3.11 to 8.25); P < 0.001), followed by patients who underwent VBG (HRadj 2.28 (95% c.i. 1.56 to 3.34); P < 0.001) and patients who underwent gastric banding (HRadj 2.34 (95% c.i. 1.37 to 4.01); P = 0.002), compared with usual obesity care. Alcohol-related mortality was significantly elevated after GBP (adjusted sub-HR (sub-HRadj) 6.18 (95% c.i. 2.48 to 15.40); P < 0.001) and VBG (sub-HRadj 3.56 (95% c.i. 1.79 to 7.08); P < 0.001) compared with usual obesity care. Mortality after gastric banding was also elevated, but did not reach statistical significance (sub-HRadj 2.52 (95% c.i. 0.89 to 7.15); P = 0.082).CONCLUSIONEffective management of alcohol-related complications in MBS patients requires preoperative risk assessment, postoperative monitoring, and access to targeted interventions for AUD.
背景:大量证据支持代谢性减肥手术(MBS)和酒精使用障碍(AUD)之间的联系,但可能导致酒精相关死亡率的因素仍不清楚。本研究的目的是检查MBS与AUD和酒精相关死亡风险之间的关系,最长可达35年。方法瑞典肥胖受试者(SOS)研究纳入了2007名接受MBS治疗的严重肥胖患者和2040名匹配的对照组(中位随访25.2年)。手术组患者接受胃旁路术(GBP, 266例)、胃束带术(376例)或垂直胃束带成形术(VBG, 1365例)。匹配的对照组在其初级保健中心接受严重肥胖的常规治疗。AUD诊断和酒精相关死亡率的数据分别来自瑞典国家患者登记册和瑞典死因登记册。结果在长期随访中,各手术组的AUD发生率有显著差异(log rank P < 0.001)。接受GBP的患者AUD风险最高(调整后HR (HRadj) 5.07 (95% ci . 3.11至8.25);P < 0.001),其次是VBG患者(HRadj 2.28 (95% ci . 1.56 ~ 3.34);P < 0.001)和接受胃束带的患者(HRadj 2.34 (95% ci: 1.37 ~ 4.01);P = 0.002),与常规肥胖护理相比。GBP后酒精相关死亡率显著升高(调整后亚危险系数(sub-HRadj) 6.18 (95% ci 2.48至15.40);P < 0.001)和VBG (hradj - 3.56 (95% ci: 1.79 ~ 7.08);P < 0.001)。胃束带术后死亡率也升高,但未达到统计学意义(hradj - 2.52 (95% ci . 0.89 ~ 7.15);P = 0.082)。结论:MBS患者酒精相关并发症的有效管理需要术前风险评估、术后监测和有针对性的AUD干预措施。
{"title":"Alcohol use disorder and alcohol-related mortality after metabolic bariatric surgery: prospective controlled cohort study.","authors":"Kajsa Sjöholm,Markku Peltonen,Peter Jacobson,Johanna C Andersson-Assarsson,Sofie Ahlin,Lucas Adméus,Ida Arnetorp,My Engström,Magdalena Taube,Lena M S Carlsson,Per-Arne Svensson","doi":"10.1093/bjs/znaf211","DOIUrl":"https://doi.org/10.1093/bjs/znaf211","url":null,"abstract":"BACKGROUNDA body of evidence supports a link between metabolic bariatric surgery (MBS) and alcohol use disorder (AUD), while the possible contribution to alcohol-related mortality remains unclear. The aim of this study was to examine the association between MBS and the risk of AUD and alcohol-related mortality over up to 35 years.METHODSThe Swedish Obese Subjects (SOS) study enrolled 2007 participants with severe obesity who underwent MBS and 2040 matched controls (median follow-up 25.2 years). Patients in the surgery group underwent gastric bypass (GBP; 266 patients), gastric banding (376 patients), or vertical banded gastroplasty (VBG; 1365 patients). The matched controls received the customary treatment for severe obesity at their primary healthcare centres. Data on AUD diagnoses and alcohol-related mortality were captured from the Swedish National Patient Register and the Swedish Cause of Death Register respectively.RESULTSDuring long-term follow-up, a significant difference in the incidence of AUD was found across surgery groups (log rank P < 0.001). Patients who underwent GBP exhibited the highest AUD risk (adjusted HR (HRadj) 5.07 (95% c.i. 3.11 to 8.25); P < 0.001), followed by patients who underwent VBG (HRadj 2.28 (95% c.i. 1.56 to 3.34); P < 0.001) and patients who underwent gastric banding (HRadj 2.34 (95% c.i. 1.37 to 4.01); P = 0.002), compared with usual obesity care. Alcohol-related mortality was significantly elevated after GBP (adjusted sub-HR (sub-HRadj) 6.18 (95% c.i. 2.48 to 15.40); P < 0.001) and VBG (sub-HRadj 3.56 (95% c.i. 1.79 to 7.08); P < 0.001) compared with usual obesity care. Mortality after gastric banding was also elevated, but did not reach statistical significance (sub-HRadj 2.52 (95% c.i. 0.89 to 7.15); P = 0.082).CONCLUSIONEffective management of alcohol-related complications in MBS patients requires preoperative risk assessment, postoperative monitoring, and access to targeted interventions for AUD.","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"158 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145246913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute pancreatitis national audit of practice: a national prospective audit of acute pancreatitis in the era of GLP-1 agonists-the PANDORA audit protocol. 急性胰腺炎国家审计实践:GLP-1激动剂时代急性胰腺炎的国家前瞻性审计-潘多拉审计方案。
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-10-03 DOI: 10.1093/bjs/znaf214
{"title":"Acute pancreatitis national audit of practice: a national prospective audit of acute pancreatitis in the era of GLP-1 agonists-the PANDORA audit protocol.","authors":" ","doi":"10.1093/bjs/znaf214","DOIUrl":"https://doi.org/10.1093/bjs/znaf214","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"115 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145261504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
'Play to the conditions': optimizing the operating theatre environment through lessons from elite performance domains. “因地制宜”:通过精英表演领域的经验来优化手术室环境。
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-10-03 DOI: 10.1093/bjs/znaf181
Connor P Boyle,James Crichton,Alessandro Sgrò,Sarah H Michael,Stephen J Wigmore,Richard J E Skipworth,Steven Yule
{"title":"'Play to the conditions': optimizing the operating theatre environment through lessons from elite performance domains.","authors":"Connor P Boyle,James Crichton,Alessandro Sgrò,Sarah H Michael,Stephen J Wigmore,Richard J E Skipworth,Steven Yule","doi":"10.1093/bjs/znaf181","DOIUrl":"https://doi.org/10.1093/bjs/znaf181","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"11 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145296201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood loss during pancreatic surgery: defining minimal clinically significant difference using standardized estimation. 胰腺手术期间的出血量:使用标准化估计定义最小的临床显著差异。
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-10-03 DOI: 10.1093/bjs/znaf215
Giampaolo Perri,Tiago Ribeiro,Aya Maekawa,Tommaso Dall'Olio,Elisa Romandini,Poya Ghorbani,Umberto Cillo,Zhi Ven Fong,Giovanni Marchegiani,Ernesto Sparrelid,Julie Hallet
{"title":"Blood loss during pancreatic surgery: defining minimal clinically significant difference using standardized estimation.","authors":"Giampaolo Perri,Tiago Ribeiro,Aya Maekawa,Tommaso Dall'Olio,Elisa Romandini,Poya Ghorbani,Umberto Cillo,Zhi Ven Fong,Giovanni Marchegiani,Ernesto Sparrelid,Julie Hallet","doi":"10.1093/bjs/znaf215","DOIUrl":"https://doi.org/10.1093/bjs/znaf215","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"126 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145296202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International Federation for the Surgery and Other Therapies for Obesity (IFSO) global consensus recommendations for optimizing outcomes after sleeve gastrectomy. 国际肥胖手术和其他治疗联合会(IFSO)关于优化袖式胃切除术后预后的全球共识建议。
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-10-03 DOI: 10.1093/bjs/znaf188
Ricardo V Cohen,Mohammad Kermansaravi,Randy Levinson,Muffazal Lakdawala,Chetan Parmar,Yosuke Seki,Gerhard Prager,Paulina Salminen,
{"title":"International Federation for the Surgery and Other Therapies for Obesity (IFSO) global consensus recommendations for optimizing outcomes after sleeve gastrectomy.","authors":"Ricardo V Cohen,Mohammad Kermansaravi,Randy Levinson,Muffazal Lakdawala,Chetan Parmar,Yosuke Seki,Gerhard Prager,Paulina Salminen, ","doi":"10.1093/bjs/znaf188","DOIUrl":"https://doi.org/10.1093/bjs/znaf188","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"64 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145296203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of long-term survival for patients with pancreatic neuroendocrine neoplasm in FinPanNET: nationwide biobank study with histopathological re-evaluation. FinPanNET中胰腺神经内分泌肿瘤患者长期生存的预测因素:全国生物银行研究和组织病理学重新评估。
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-10-03 DOI: 10.1093/bjs/znaf197
Susanna Majala,Lauri Elonen,Tuomas Kaprio,Tiina Vesterinen,Saila Kauhanen,Henna Sammalkorpi,Helka Parviainen,Camilla Schalin-Jäntti,Jukka Schildt,Johanna Laukkarinen,Reea Ahola,Lasse Nieminen,Irina Rinta-Kiikka,Johanna Ronkainen,Kalle Sipilä,Minna Nortunen,Heikki Karjula,Heikki Huhta,Vesa-Matti Pohjanen,Markus Mäkinen,Mirvamaaria Söderström,Jukka Kemppainen,Johanna Mrena,Teijo Kuopio,Anna-Stiina Koivula,Tuomo Rantanen,Jukka Pulkkinen,Reijo Sironen,Caj Haglund,Johanna Arola,Hanna Seppänen
{"title":"Predictors of long-term survival for patients with pancreatic neuroendocrine neoplasm in FinPanNET: nationwide biobank study with histopathological re-evaluation.","authors":"Susanna Majala,Lauri Elonen,Tuomas Kaprio,Tiina Vesterinen,Saila Kauhanen,Henna Sammalkorpi,Helka Parviainen,Camilla Schalin-Jäntti,Jukka Schildt,Johanna Laukkarinen,Reea Ahola,Lasse Nieminen,Irina Rinta-Kiikka,Johanna Ronkainen,Kalle Sipilä,Minna Nortunen,Heikki Karjula,Heikki Huhta,Vesa-Matti Pohjanen,Markus Mäkinen,Mirvamaaria Söderström,Jukka Kemppainen,Johanna Mrena,Teijo Kuopio,Anna-Stiina Koivula,Tuomo Rantanen,Jukka Pulkkinen,Reijo Sironen,Caj Haglund,Johanna Arola,Hanna Seppänen","doi":"10.1093/bjs/znaf197","DOIUrl":"https://doi.org/10.1093/bjs/znaf197","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"119 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145283517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic retrograde appendicitis therapy versus laparoscopic appendectomy for uncomplicated acute appendicitis with appendicoliths: a multicentre retrospective cohort study. 内镜逆行阑尾炎治疗与腹腔镜阑尾切除术治疗无并发症急性阑尾炎伴阑尾结石:一项多中心回顾性队列研究
IF 9.6 1区 医学 Q1 SURGERY Pub Date : 2025-10-03 DOI: 10.1093/bjs/znaf219
Zhu-Hui Liu,Xiang-Rong Zhou,Shengtao Liao,Tian-Yu Liu,Yang Liu,Yuan-Zhi Wang,Min Qiao,Xue-Qin Li,Yan-Bing Ding,Wei-Hui Liu
{"title":"Endoscopic retrograde appendicitis therapy versus laparoscopic appendectomy for uncomplicated acute appendicitis with appendicoliths: a multicentre retrospective cohort study.","authors":"Zhu-Hui Liu,Xiang-Rong Zhou,Shengtao Liao,Tian-Yu Liu,Yang Liu,Yuan-Zhi Wang,Min Qiao,Xue-Qin Li,Yan-Bing Ding,Wei-Hui Liu","doi":"10.1093/bjs/znaf219","DOIUrl":"https://doi.org/10.1093/bjs/znaf219","url":null,"abstract":"","PeriodicalId":136,"journal":{"name":"British Journal of Surgery","volume":"25 1","pages":""},"PeriodicalIF":9.6,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145296200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
British Journal of Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1